Nature Reviews Drug Discovery

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Nature Reviews Drug Discovery  
Nature Review Drug Discovery.jpg
Abbreviated title (ISO 4)
(Nat Rev Drug Discov)
Discipline pharmacology
biotechnology
microbiology
Language English
Publication details
Publisher
Nature Publishing Group (international)
Publication history
2002-
Frequency monthly
no
37.231
Indexing
ISSN 1474-1776 (print)
1474-1784 (web)
Links

Nature Reviews Drug Discovery is a review journal with an emphasis on drug discovery and development.[1] With an impact factor of 37.231 in 2013 it is the leading journal in pharmacology/pharmacy and biotechnology/applied microbiology areas.

The reviews are commissioned to leaders in the their specialties (non-commissioned review submissions are discouraged), but are also peer-reviewed after submission. The reviews are supplemented with glossary explanations for non-specialist readers and illustrated with figures drawn by Nature's in-house art editors. Besides reviews, the journal accepts peer-reviewed analysis articles based on existing datasets (e.g. metaanalysis), progress articles that focus on outstanding issues, and perspective articles—typically opinions or historical pieces.[2]

See also[edit]

References[edit]

  1. ^ Journal Scope : Information : Nature Reviews Drug Discovery. Nature.com (2008-06-20). Retrieved on 2011-06-29.
  2. ^ Guide : Information : Nature Reviews Drug Discovery. Nature.com. Retrieved on 2011-06-29.